Form 4: Opus Genetics CEO George Magrath Reports Stock Disposal
SEC Form 4 Filing
CEO George Magrath reported disposing of 37,050 shares of Opus Genetics, Inc. common stock to cover tax obligations.
Summary
- On November 1, 2024, George Magrath, the CEO of Opus Genetics, Inc., disposed of 37,050 shares of common stock.
- The transaction was executed at a price of $1.18 per share.
- This disposal was likely to cover tax obligations related to vesting of restricted stock or similar compensation.
- Following the transaction, Magrath directly owns 392,950 shares of Opus Genetics, Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of stock disposal by an insider, likely for tax purposes. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. This filing indicates a stock disposal by the CEO, which is a common occurrence for covering tax obligations related to stock-based compensation.
Stakeholder Impact
- The stock disposal may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply, but this is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 11/01/2024 | Date of stock disposal transaction |
| 11/05/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.